The Hidden Operational Implications of MFN Drug Pricing
May 6, 2026The Most Favored Nation (MFN) drug pricing policy is gaining momentum in the United States. While the policy’s breadth of implementation is still unclear, pharmaceutical manufacturers must be ready for the full range of potential market disruptions. All 17 pharmaceutical manufacturers named by the Trump administration have made individual deals…